Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s ...

Using a new animal model of Alzheimer’s disease, the study highlights a potential breakthrough in treatment strategies.

The root causes of most forms of Alzheimer's disease largely remain a mystery. Now, researchers have revealed a new piece of the puzzle.

At the Human Amyloid Imaging (HAI) meeting, held January 15-17, researchers focused on new techniques—all based on tau and ...

Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer’s disease, formed by the accumulation of tau protein into ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...

Furthermore, NFTs may also contribute to the disease progression by effectively sequestering more tau and other proteins, and thereby reinforcing and amplifying the loss of normal tau function.